The usefulness of inspiratory flow rate during inhalation corticosteroid therapy in asthma

Respiration

Volumn 78, Issue 4, 2009, Pages 387-392

  Banno, Masashi ^a,b   Ibata, Hidenori ^a   Niimi, Takashi ^b   Sato, Shigeki ^c   Matsushita, Ryo ^d  

^a National Hospital Organization Mie Chuo Medical Center   (Japan)

^b NAGOYA CENTRAL HOSPITAL   (Japan)

^c NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^d KANAZAWA UNIVERSITY   (Japan)

Author keywords

In Check device; Inhalation therapy; Peak inspiratory flow rate

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; FLUORINATED HYDROCARBON; FLUTICASONE PROPIONATE;

ADULT; AGED; ARTICLE; ASTHMA; CORTICOSTEROID THERAPY; DEVICE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALER; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PEAK INSPIRATORY FLOW; PRIORITY JOURNAL; TREATMENT RESPONSE;

ADMINISTRATION, INHALATION; ADULT; AGED; AGED, 80 AND OVER; ANDROSTADIENES; ASTHMA; BECLOMETHASONE; BRONCHODILATOR AGENTS; BUDESONIDE; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROCARBONS, FLUORINATED; INHALATION; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS;

EID: 70350292695     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000220097     Document Type: Article

References (24)

1. National Institutes of Health, National Heart, Lung, and Blood Institute: Global Initiative for Asthma. Global strategy for asthma management and prevention, updated 2006. http://www.ginasthma.com.
2. Humbert M: The right tools at the right time. Chest 2006; 130(suppl 1):29S-40S.
3. Ankerst J: Combination inhalers containing inhaled corticosteroids and long-acting beta2-agonists: Improved clinical efficacy and dosing options in patients with asthma. J Asthma 2005; 42: 715-724.
4. Adachi YS, Adachi Y, Itazawa T, Yamamoto J, Murakami G, Miyawaki T: Ability of preschool children to use dry powder inhalers as evaluated by In-Check Meter. Pediatr Int 2006; 48: 62-65.
5. Amirav I, Newhouse MT, Mansour Y: Measurement of peak inspiratory flow with incheck dial device to simulate low-resistance (Diskus) and high-resistance (Turbohaler) dry powder inhalers in children with asthma. Pediatr Pulmonol 2005; 39: 447-451.
6. Borgstrom L, Asking L, Thorsson L: Idealhalers or realhalers? A comparison of Diskus and Turbuhaler. Int J Clin Pract 2005; 59: 1488-1495.
7. van Schayck CP, Donnell D: The efficacy and safety of QVAR (hydrofluoroalkane-beclometasone diproprionate extrafine aerosol) in asthma (part 1): An update of clinical experience in adults. Int J Clin Pract 2004; 58: 678-688. (Pubitemid 39144583)
8. van Schayck CP, Donnell D: The efficacy and safety of QVAR (hydrofluoroalkane-beclometasone diproprionate extrafine aerosol) in asthma (part 2): Clinical experience in children. Int J Clin Pract 2004; 58: 786-794. (Pubitemid 39232324)
9. Worth H, Muir JF, Pieters WR: Comparison of hydrofluoroalkane- beclomethasone dipropionate Autohaler with budesonide Turbuhaler in asthma control. Respiration 2001; 68: 517-526.
10. Ohbayashi H: One-year evaluation of the preventative effect of hydrofluoroalkanebeclomethasone dipropionate on eosinophilic inflammation of asthmatic peripheral airways. Respiration 2007; 74: 146-153.
11. Fiato KL, Iwamoto GK, Harkins MS, Morelos J: Monitoring flow rates and retention of inhalation techniques using the in-check dial device in adult asthmatics. J Asthma 2007; 44: 209-212.
12. van der Palen J: Peak inspiratory flow through Diskus and Turbuhaler, measured by means of a peak inspiratory flow meter (In-Check DIAL). Respir Med 2003; 97: 285-289.
13. Brown PH, Ning AC, Greening AP, McLean A, Crompton GK: P eak inspiratory flow through Turbuhaler in acute asthma. Eur Respir J 1995; 8: 1940-1941.
14. Tanaka H, Hashimoto M, Sahara S, Ohnishi T, Fujii M, Suzuki K, Saikai T, Abe S: P athological and radiological approach to the small airway disease in asthma: Limitation of current inhaled corticosteroid therapy. Allergol Int 2004; 53: 1-6.
15. Bentur L, Mansour Y, Hamzani Y, Beck R, Elias N, Amirav I: Measurement of inspiratory flow in children with acute asthma. Pediatr Pulmonol 2004; 38: 304-307.
16. Nielsen KG, Auk IL, Bojsen K, Ifversen M, Klug B, Bisgaard H: Clinical effect of Diskus dry-powder inhaler at low and high inspiratory flow-rates in asthmatic children. Eur Respir J 1998; 11: 350-354.
17. Broeders ME, Molema J, Hop WC, Folgering HT: Inhalation profiles in asthmatics and COPD patients: Reproducibility and effect of instruction. J Aerosol Med 2003; 16: 131-141.
18. Kamps AW, Brand PL, Roorda RJ: Variation of peak inspiratory flow through dry powder inhalers in children with stable and unstable asthma. Pediatr Pulmonol 2004; 37: 65-70.
19. Broeders ME, Molema J, Vermue NA, Folgering HT: In Check Dial: Accuracy for Diskus and Turbuhaler. Int J Pharm 2003; 252: 275-280.
20. Leach CL, Davidson PJ, Boudreau RJ: Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone. Eur Respir J 1998; 12: 1346-1353.
21. Ederle K; Multicentre Study Group: Improved control of asthma symptoms with a reduced dose of HFA-BDP extrafine aerosol: An open-label, randomised study. Eur Rev Med Pharmacol Sci 2003; 7: 45-55.
22. Brocklebank D, Wright J, Cates C: Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering corticosteroids in asthma. BMJ 2001; 323: 896-900. (Pubitemid 32980478)
23. Weiner P, Weiner M: Inspiratory muscle training may increase peak inspiratory flow in chronic obstructive pulmonary disease. Respiration 2006; 73: 151-156.
24. Wieshammer S, Dreyhaupt J: Dry powder inhalers: Which factors determine the frequency of handling errors? Respiration 2008; 75: 18-25.